Validity of bioconjugated silica nanoparticles in comparison with direct smear, culture, and polymerase chain reaction for detection of Mycobacterium tuberculosis in sputum specimens by Ekrami, Alireza et al.
© 2011 Ekrami et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
International Journal of Nanomedicine 2011:6 2729–2735
International Journal of Nanomedicine
Validity of bioconjugated silica nanoparticles  
in comparison with direct smear, culture,  
and polymerase chain reaction for detection  
of Mycobacterium tuberculosis in sputum specimens
Alireza Ekrami1
Ali Reza Samarbaf-Zadeh2
Azar Khosravi1
Behrooz Zargar3
Mohamad Alavi1
Mansor Amin2
Alireza Kiasat3
1Infectious and Tropical Diseases 
Research Center, Ahvaz Jundishapur 
University of Medical Sciences, 
2Department of Microbiology, School 
of Medicine, Ahvaz Jundishapur 
University of Medical Sciences, 
3Department of Chemistry, School of 
Science, Shahid Chamran University, 
Ahvaz, Iran
Correspondence: Alireza Ekrami 
Infectious and Tropical Diseases  
Research Center, Ahvaz Jundishapur 
University of Medical Sciences,  
Ahvaz, Iran 
Tel +98 61 1383 7317 
Fax +98 61 1373 8330 
Email aekrami@yahoo.com
Background: Tuberculosis is a public health problem worldwide, and new easy to perform 
diagnostic methods with high accuracy are necessary for optimal control of the disease. Recently, 
fluorescent silica nanoparticles (FSNP) has attracted immense interest for the detection of 
pathogenic microorganisms. The aim of this study was to detect Mycobacterium tuberculosis in 
clinical samples using bioconjugated FSNP compared with microscopic examination,   polymerase 
chain reaction (PCR), nested PCR, and culture as the gold standard.
Methods: In total, 152 sputum specimens were obtained from patients who were suspected to 
have pulmonary tuberculosis. All samples were examined by the four techniques described.
Results: The assay showed 97.1% sensitivity (95% confidence interval [CI] 91–99.2) and 
91.35% specificity (CI 78.3–97.1). Furthermore, assays using variable bacterial concentrations 
indicated that 100 colony forming units/mL of M. tuberculosis could be detected. There were 
no differences between the results obtained from two types of mouse monoclonal antibody 
against Hsp-65 and 16 KDa antigens.
Conclusion: We performed this assay in a large number of clinical samples to confirm the 
diagnostic specificity and sensitivity of the test and can recommend its application for diagnosis 
of M. tuberculosis. We believe that this method is more convenient for routine diagnosis of 
M. tuberculosis in sputum and will be more easily applicable in the field, and with sufficient 
sensitivity.
Keywords: Mycobacterium tuberculosis, fluorescent silica nanoparticles, bioconjugation, 
IS6110
Introduction
Tuberculosis is a public health problem of global importance. Mycobacterium 
  tuberculosis is the main etiology of the disease. According to the World Health 
  Organization, in 2009 there were an estimated 9.4 million incident cases of tubercu-
losis globally (equivalent to 137 cases per 100,000 population), and approximately 
1.7 million people died of tuberculosis in that year. The absolute number of cases 
continues to increase slightly every year. Most of the cases in 2009 (55%) occurred in 
Asia.1,2   Multidrug-resistant and extensively drug-resistant strains of M. tuberculosis are 
spreading rapidly, so this bacterium poses a serious dilemma for public health. There 
were an estimated 440,000 cases of multidrug-resistant tuberculosis in 2008. Drug-
resistant isolates of M. tuberculosis have been found in all countries. The four countries 
that had the largest number of estimated cases of multidrug-resistant   tuberculosis 
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in 2008 were China, India, the Russian   Federation, and 
South Africa.3 Rapid detection of tuberculosis is extremely 
important for early therapy and designing control measures 
for prevention of the spread of bacteria in the human popula-
tion and inhibiting emergence of multidrug-resistant and/
or extensively drug-resistant isolates. The gold standard 
for diagnosis of tuberculosis is the cultivation of M. tuber-
culosis.   Cultivation can detect 100 bacilli/mL of sputum 
in comparison with the 5,000–10,000 bacilli/mL needed 
for microscopy.4   Commercial biochemical kits are avail-
able for the detection and phenotypic characterization of 
M. tuberculosis, but molecular methods developed in recent 
years are more rapid and accurate for this purpose.5   Generally, 
molecular methods offer several advantages over conven-
tional techniques for rapid detection and identification of 
  mycobacterium. However, molecular methods are expensive 
and require more skilled personnel, so that implementation 
of these methods is difficult, especially in regions where M. 
tuberculosis infection is more common.6 Rapid and accurate 
detection of trace amounts of organisms, such as pathogenic 
bacteria, is important for clinical diagnosis and prevention 
of accidental outbreaks. Recently, nanoparticles have been 
successfully used for detection of micro-organisms. Unlike 
traditional methods for the detection of bacteria, which 
require amplification or enrichment of the target bacteria in 
samples, fewer numbers of bacteria are needed for detec-
tion by the nanoparticle method in a shorter time.7 Some 
of  the different nanomaterials developed can be used as a 
convenient surface for the attachment of      biomolecules. They 
can be used as a convenient surface for molecular assembly 
and may be composed of inorganic or polymeric materials.8 
Stöber et al first reported a method for synthesis of a dye-
doped nanoparticle which encapsulates many thousands 
of dye molecules inside silica nanoparticles.9,10 There are 
several advantages to using dye-doped silica nanoparticles, 
including their small size (20–70 nm in diameter) bright-
ness, photostability, and ease of functionalization. Using 
surface modification, it is possible to conjugate a dye-doped 
silica nanoparticle to a particle, so that thousands of dye 
molecules can be attached to a biomolecule. Consequently, 
a significantly greater signal is emitted from signal binding 
events, which leads to increased sensitivity in comparison 
with a single fluorophore-labeled assay.11 Recently, a study 
was reported for detection of M. tuberculosis using a ref-
erence strain of M. tuberculosis.12 The aim of the present 
study was to evaluate the validity of the FSNP assay in 
comparison with culture as the gold standard, acid-fast 
staining, and polymerase chain reaction (PCR) in order to 
develop a simple, rapid, and sensitive method for detection 
of M. tuberculosis in sputum specimens.
Materials and methods
Tris (2,2′-bipyridyl) dichlororuthenium(II) hexahydrate(RuBpy), 
Triton X-100, protein A from Staphylococcus aureus, 
acetonitrile, glycine, N acetyl-L-cysteine (NALC), cyanogen 
bromide, tetraethyl orthosilicate (TEOS), n-hexanol, cyclo-
hexane, acetone, ammonium hydroxide (NH4OH, 28–30 wt%) 
were purchased from Sigma-Aldrich (St Louis, MO). All other 
chemicals were of analytical reagent grade. Mouse IgG (IgG2a) 
monoclonal antibodies to M. tuberculosis were purchased from 
AbCam (Cambridge, UK) against Hsp-65 antigen and AbD 
Serotec (Oxford, UK) against 16 KDa antigen. Lowenstein-
Jensen medium (Merck, Darmstadt, Germany) was used 
for culture of M. tuberculosis. Primer oligonucleotides for 
conventional and nested PCR were purchased from TaG Co 
(Copenhagen, Denmark). Distilled deionized water was used 
in the preparation of all aqueous solutions. A standard strain 
of reference M. tuberculosis (H37Rv) and Escherichia coli 
(American Type Culture Collection 2532) were obtained from 
the Pasteur Institute in Iran.
Instrumentation
An atomic force microscope (SPM probe scanner DS 
95–50 E, Danish Microengineering A/S, Herlev, Denmark) 
and particle size analyzers (Analystte 22-Nano Tec, Fritsch, 
Germany) were used for visualization of the morphology 
and estimation of the size of the silica nanoparticles. Protein 
concentration was evaluated using a ultraviolet-visible spec-
trophotometer (Biphotometer Plus, Eppendorf, Germany). 
A spectrofluorometer (RF-5301 PC, Shimadzu, Japan), and 
an ultraviolet-visible spectrophotometer (Varian Carry-100, 
Australia) was used for evolution of emission and absor-
bance of nanoparticles after synthesis. The presence of an 
amide group after conjugation of protein A was confirmed 
using an infrared spectrometer (Bomem MB 155S FT-IR 
  spectrometer, ABB Bomem Inc, Canada). A Techne TC 
thermal cycler (Techne Co Ltd, Leicester, UK) for ampli-
fication of extracted DNA, and a fluorescent microscope 
(Olympus BX51 and DP70 digital camera system, Olympus 
America Inc, Center Valley, PA) was used for visualization 
of microscopic slides and their imaging.
Sputum collection and processing
One hundred and fifty-three sputum samples were obtained 
from the reference mycobacteriology laboratory at Ahvaz 
Jundishapur University of Medical Sciences from March 
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2009 to April 2010. All specimens were collected from 
patients who were suspected to have pulmonary   tuberculosis. 
Specimens were examined by four techniques, ie,   microscopic 
examination, culture, PCR, and FSNP assay. Specimens were 
processed immediately according to standard routine diag-
nostic procedures using the NALC method.13 Mycobacteria 
were concentrated for culture and smear preparation, and 
250 µL of each concentrated sample were inoculated into 
Lowenstein–Jensen media. All cultures were incubated at 
37°C with 5% CO2 and humidity. After 8 weeks of incuba-
tion, cultures showing no growth were reported as negative 
and discarded. For microscopic examination, using a dispos-
able Pasteur pipette, one drop of the sediment of the sputum 
specimen was spread onto a clean microscopic slide and, 
after air-drying and fixation by heat, the smears were stained 
using the Ziehl–Neelsen method.14
DNA extraction and PCR assay
Chromosomal DNA was extracted using proteinase K and 
phenol:chloroform, then precipitated by ethanol and isopro-
panol according to a method described elsewhere.15 Purified 
DNA was amplified with a pair of primers specific to the 
M. tuberculosis complex strains (IS6110) and two specific 
pairs of external and internal primers for this   bacterium (ie, 
nested PCR). Conventional and nested PCR for   detection of 
M. tuberculosis were performed as described by Eisenach et al16 
and Wilson et al, respectively17 (Table 1 and Figure 1).
Synthesis of dye-doped silica 
nanoparticles
RuBpy-doped silica nanoparticles were synthesized using 
a microemulsion method as described by Stöber et al.9,18 In 
brief, a microemulsion was prepared by addition of 20 mM 
RuBpy dye to water (0.48 mL), TEOS 100 µL, cyclohexane 
7.5 mL, n-hexanol 1.8 mL, and Triton X-100 1.77 mL. After 
mixing for 20 minutes, 60 µL of NH4OH was added to initi-
ate   polymerization. The reaction was allowed to continue for 
24 hours. The nanoparticles were isolated by destabilizing the 
water-in-oil microemulsion system using acetone, followed by 
centrifuging and washing with ethanol and water several times 
to remove any surfactant molecules. The fluorescent intensity, 
size, and shape of the synthesized nanoparticles was evaluated 
using a spectrofluorometer, atomic force microscope, and par-
ticle size analyzer, as described previously. The shape and size 
of the silica nanoparticles are shown in Figures 2 and 3.
Surface modification of FSNP and 
covalent immobilization of protein A
There are several methods available to biofunctionalize 
silica nanoparticles, including amino group cross-linkage, 
avidin-biotin linkage bridge, disulfide coupling, chemical 
binding, and cyanogen bromide modification. In this assay, 
we used cyanogen bromide for surface modification of silica 
nanoparticles in order to immobilize protein A covalently 
on FSNP. Protein A is a highly stable cell surface receptor 
produced by several strains of Staphylococcus aureus. This 
protein is capable of binding to the Fc portion of immuno-
globulins, especially IgGs, from a large number of species. 
One molecule of this protein is capable of binding to at least 
two molecules of IgG simultaneously.19 Using this tech-
nique, FSNP with a natural surface sianol group is activated 
by cyanogen bromide reagent, forming a reactive –OCN 
  derivative of FSNP. Briefly, a solution of cyanogen bromide 
in acetonitrile is added to a suspension of silica nanoparticles 
to yield an –OCN group on the particle surface.20 The par-
ticles are then available for bioconjugation to the protein A 
biomolecules containing free amino groups. To block the 
protein A-immobilized nanoparticles, 6 mL of 0.3 M glycine 
Table 1 Characteristics of DNA oligonucleotide primers used for IS6110-based Mycobacterium tuberculosis complex polymerase chain 
reaction and nested polymerase chain reaction for detection of M. tuberculosis
Primer 
name
Target 
DNA
Sequences (5′–3′) Length Target  
position
Amplicon  
size (bp)
Reference
PCR
IS1
IS2
IS6110 CTCgTCCAgCgCCgCTTCgg 20-mer 762–781 123 18
CCTgCgAgCgTAggCggTgg 20-mer 856–884
Nested PCR
Outer set
TB 294
TB 850
IS6110 ggACAACgCCgAATTgCgAAgggC 24-mer 295–318 580 19
TAggCgTCggTgACAAAggCCACg 24-mer 851–874
Inner set
TB 505
TB 670
IS6110 ACgACCACATCAACC 15-mer 505–515 181 19
AgTTTggTCATCAgCC 16-mer 670–685
Abbreviation: PCR, polymerase chain reaction.
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Figure 2 Atomic force microscopic image of the dye-doped silica nanoparticles.
580bp
200bp
183bp
100bp
5 4
100bp
200bp
123bp
2 13 M7 6 A M B 9 8
Figure 1 Conventional and nested polymerase chain reaction products of Mycobacterium tuberculosis IS6110 fragment by agarose gel electrophoresis (2%). (A) Nested 
polymerase chain reaction, M 100 bp DNA size marker, (second round) (1) positive control, (2) clinical positive sample, (3) negative control (first round), (4) positive control, 
(5) clinical positive sample. (B) Conventional polymerase chain reaction, (6) positive control, (7, 8) positive clinical samples, (9) negative control.
solution (pH 8.0) is added and incubated for 16 hours at 4°C. 
For quality control, the amount of immobilized protein A on 
the nanoparticles is measured using the Bradford method.21 
The presence of an amide group (–NHCO–) is confirmed by 
infrared spectra assay.
Bioconjugation of a specific monoclonal 
antibody to M. tuberculosis
In the next step, mouse monoclonal anti-M. tuberculosis 
antibody was conjugated to the agents in the sputum 
specimen. Briefly, mouse monoclonal antibody was 
added to 500 µL of a sediment suspension of sputum in 
phosphate-buffered saline following processing (final 
antibody concentration 5 µg/mL), and after 1 hour of 
incubation at 37°C, the suspension was washed twice 
with phosphate-buffered saline. Afterwards, 0.1 mg/mL 
of protein A-conjugated nanoparticles were added, and the 
suspension was incubated for 1 hour at 37°C. Free FSNP 
protein A-conjugates which did not bind to bacteria were 
removed by centrifugation (8000 rpm per 2 minutes). The 
primary amine group of the M. tuberculosis monoclonal 
antibody was reacted with the activated FSNP, forming 
antibody-conjugated FSNP.
Microscopic examination
The fluorescent microscope used in this project was equipped 
with a 450–490 nm band pass excitation and a 515 nm long 
pass emission filter. The pellet was spread on a glass slide and 
observed by fluorescent microscopy. Figure 5 is a schematic 
representation of this method for detecting M. tuberculosis. 
To remove the fluorescence background during   microscopic 
examination, quartz microscope slides (UQG Optics, 
  Cambridge, UK) were used (Figure 4).
Determination of limit of bacterial 
detection by FSNP assay
In this step, the ability of culture and FSNP assay for 
detection of different M. tuberculosis concentrations was 
  evaluated. A single cell suspension was prepared by   harvesting 
M. tuberculosis (H37Rv strain) in phosphate-buffered saline 
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Data analysis
Analysis of the data was performed using the SPSS 15 (SPSS 
Inc, Chicago, IL), and diagnostic sensitivity and specificity 
and other statistical parameters were calculated using Stats-
Direct statistical software (Version 2.7.2). The investigators 
were blinded to the clinical data and samples used during the 
experiment for detection of M. tuberculosis.
Results
Smear of sputum, culture, PCR, and FSNP assays were 
performed for all the 152 specimens taken from patients. 
Reference strains were treated similarly to the field samples. 
By acid-fast staining, 63.2% (96/152) of the specimens were 
positive for M. tuberculosis, while 69.7% (106/152) were 
culture-positive. Of 152 samples, 86 (56.6%) were positive 
by PCR and 100 (65.8%) were positive by nested PCR for 
M. tuberculosis.
Of the 152 specimens, 107 (70.3%) were positive by FSNP 
assay. Of 107 specimens, 103 (96.2%) were culture-positive 
and 88 (82%) were positive by both acid-fast staining and 
culture. Thus, four samples that were positive by FSNP assay 
were reported negative by the culture method. Furthermore, 
of these 107 samples, 78 (72.8%) were positive by both PCR 
and nested PCR techniques, and 10 samples were negative 
by both techniques (Table 2).
Comparison of limit of bacterial 
detection by FSNP and culture methods
The limits of the FSNP assay against culture for the bacte-
rial agent was calculated in this section. As described pre-
viously, all bacterial solutions were tested in duplicate for 
  confirmation. Limits of detection for both methods were 100 
colony   forming units/mL, ie, there was no difference between 
the two methods in ability to detect bacteria in solution.
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Figure 3 Size particle image profile on atomic force microscopy.
Figure 4 Fluorescence images (100× oil). (A) negative control, phosphate-buffered 
saline in place of the specific monoclonal antibody, (B) negative control, Escherichia 
coli in place of the Mycobacterium tuberculosis. (C, D and F) Specific interaction of 
bioconjugated  nanoparticles  with  M.  tuberculosis;  (E)  the  nonspecific  interaction 
(autofluorescence) despite displaying M. tuberculosis with a bright fluorescence.
M. tuberculosis with surface
antigens
Specific monoclonal antibody
Immobilized protein A on
fluorescent nanoparticle 
Figure 5 Schematic illustration for detecting Mycobacterium tuberculosis based on 
fluorescent silica nanoparticle assay.
(pH 7.4) using a previously described method.22 The bacterial 
suspension was counted in a Petroff-Hausser chamber. Differ-
ent concentrations of bacteria (10,000, 5000, 1000, 500, 100, 
50, and 10 colony forming units/mL) were prepared. Distilled 
water was used as a negative control in the process, and a sus-
pension of M. tuberculosis adjusted to 0.5 McFarland turbidity 
(about 109 colony forming units/mL) was used as a positive 
control. All experiments were performed in duplicate.
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Table 2 Comparison of four techniques versus culture method 
for diagnosis of Mycobacterium tuberculosis
Techniques Culture (gold standard)  Values
Positive 
n
Negative 
n
Sensitivity 
%
Specificity 
%
FSNP assay
Positive 
Negative
103 
3
4 
42
97.1 91.3
Total 106 46
Acid-fast staining
Positive 
Negative
90 
16
6 
40
86 84.9
Total 106 46
PCR
Positive 
Negative
78 
28
8 
38
82.6 73.5
Total 106 46
Nested PCR
Positive 
Negative
94 
12
6 
40
86.9 88.6
Total 106 46
Abbreviations:  PCR,  polymerase  chain  reaction;  FSNP,  fluorescent  silica 
nanoparticles.
Analytical specificity and sensitivity
In the present study, the overall diagnostic sensitivity, specificity, 
efficiency, predictive value for a positive test, and predictive 
value for a negative test using the FSNP assay versus culture 
as a gold standard method were 97.1% (95% CI 91.3–99.2), 
91.3% (95% CI 78.3–97.1), 95.5% (efficiency), 96.2% (95% 
CI 90.1–98.7), and 93.3% (95% CI 80.6–98.2),   respectively. 
The sensitivity and specificity of the other techniques performed 
in this study are shown in Table 2. As previously described, 
two types of mouse monoclonal antibody against Hsp-65 and 
16 kDa antigen from the M. tuberculosis surface antigen group 
were used for confirmation of the FSNP method. No differ-
ences were found in the results obtained with the two different 
monoclonal antibodies for detection of M. tuberculosis.
Discussion
In spite of considerable advances in the diagnosis of 
M. tuberculosis, the gold standard method for laboratory 
diagnosis is culture. Initiation of appropriate therapy is the 
main reason for developing a rapid test for diagnosis of pul-
monary tuberculosis. In this era of molecular   biology, efforts 
are focused on development of more rapid and   sensitive 
tests. Recent advances in the field of nanoscience have pro-
vided new opportunities for rapid laboratory diagnosis of 
tuberculosis. The specificity, sensitivity, and rapidity of this 
method encouraged us to trial this technique for detection of 
M. tuberculosis in sputum. In this paper, we have reported the 
feasibility of the FSNP assay for detection of M. tuberculosis 
and compared this assay with other detection methods.
Recently, two studies were performed to detect bacteria 
using bioconjugated silica nanoparticles. Qin et al showed 
the ability of bioconjugated RuBpy-doped nanoparticles to 
detect M. tuberculosis in pure and mixed bacterial samples 
in comparison with commercial FITC-conjugated   antirabbit 
M. tuberculosis antibody.12 The other study, reported by 
Zhao et al, described the detection of E. coli O157:H7 in 
ground beef samples.7 They reported a high intensity of fluo-
rescence signals, a decrease in the amount of primary anti-
body, and detection of a single bacterium within 20 minutes 
as major advantages of this technique in their research.
It is noteworthy that the above studies were performed 
on standard strains, whereas in our study we used the FSNP 
assay in clinical specimens. Moreover, based on our data, the 
sensitivity and specificity values were both more than 90%, 
confirming the accuracy of this method.
In another study, these nanoparticles were used by 
Zhou et al as probes for DNA/microarray detection.23 They 
reported a higher sensitivity for target DNA compared with 
fluorophores. The sensitivity and specificity of the molecular 
detection system and nanoparticle probe method is dependent 
on the amount of DNA or the primer sequence. DNA or primer 
sequences were not used as the template in our method, and 
thus did not play any role in sensitivity and specificity.
Despite the use of a definite filter for microscopic   imaging, 
an interface by autofluorescent signals was   exhibited by a 
few samples during our experiments   (Figure 4E). All four 
samples that were negative by FSNP assay and positive by 
culture showed autofluorescent signals during microscopic 
examination. This problem has not been described in   previous 
reports.9,7,12 It seems that there is a specific problem when clini-
cal samples are examined. In general, interface by autofluores-
cence can result from natural factors induced by some reagents 
and unspecific binding of antibodies to Fc receptors.24,25
In addition to increased sensitivity and specificity, another 
advantage of the FSNP assay compared with the conventional 
and PCR methods is the short duration of the procedure. 
Indeed, only 2–3 hours are needed to perform the FSNP 
assay compared with 6–8 weeks for the culture and 5 hours 
for the nested PCR assay.
The limit of the FSNP assay for detection of M.   tuberculosis 
was performed on pure bacteria and found to be 100 colony 
forming units/mL. Less than 100 colony forming units/mL 
was not detected by either FSNP assay or culture. However, 
in clinical samples, we found some cases that were   positive 
in culture but negative on FSNP assay, and the overall 
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sensitivity of the FSNP assay versus culture was not 100% 
but 97%. The FSNP assay in comparison with PCR is cost-
effective ($1.0–$1.5 per test) and the results come out in a 
shorter time. We believe the sensitivity and specificity of 
this method will enable it to become a routine technique for 
detection of M. tuberculosis in clinical specimens.
Conclusion
Compared with the gold standard method of culture, the total 
assay time and ease of performing the FSNP assay suggests 
that this technique can be of great use in the future. We per-
formed the FSNP assay on a large number of clinical samples 
to confirm its diagnostic specificity and sensitivity, and con-
sider it reliable enough for routine use in laboratories.
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